MRP Antibodies

Santa Cruz Biotechnology features a diverse variety of MRP Antibodies for studying multidrug resistance proteins. MRP Antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Multidrug resistance proteins play a critical role in the transport of various substrates across cellular membranes, influencing drug absorption, distribution, and elimination. Their function is particularly important in cancer research, as multidrug resistance proteins can contribute to the failure of chemotherapy by expelling therapeutic agents from cancer cells. Understanding the mechanisms of MRP proteins can lead to the development of more effective treatment strategies. MRP Antibodies enable researchers to explore protein expression patterns in different tissue types and cellular compartments. Investigating MRP protein interactions and regulatory pathways provides valuable information about drug resistance mechanisms. Detailed characterization of MRP proteins advances our understanding of cellular transport systems and their impact on therapeutic outcomes. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge about multidrug resistance and developing improved therapeutic approaches.